Familial small cell carcinoma of the ovary

Pediatric Blood and Cancer

Volumn 53, Issue 7, 2009, Pages 1334-1336

  Martinez Borges, Anibal R ^a   Petty, John K ^a   Hurt, Gail ^a   Stribling, Jennifer T ^a   Press, Joshua Z ^b   Castellino, Sharon M ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer genetics; Hereditary cancer; Hypercalcemia; Ovary; Rare tumors; Small cell carcinoma

Indexed keywords

BLEOMYCIN; BRCA1 PROTEIN; BRCA2 PROTEIN; CA 125 ANTIGEN; CALCIUM; CISPLATIN; ETOPOSIDE; URIC ACID; ANTINEOPLASTIC AGENT; BEP PROTOCOL;

ABDOMINAL RADIOGRAPHY; ARTICLE; CALCIUM BLOOD LEVEL; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CASE REPORT; CHILD; COMPUTER ASSISTED TOMOGRAPHY; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENE SEQUENCE; HUMAN; HYPERCALCEMIA; IMMUNOHISTOCHEMISTRY; LAPAROTOMY; MULTIPLE CYCLE TREATMENT; ONSET AGE; OVARY CARCINOMA; OVARY SMALL CELL CARCINOMA; PERITONEAL BIOPSY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SALPINGOOOPHORECTOMY; SCHOOL CHILD; URIC ACID BLOOD LEVEL; ABDOMINAL PAIN; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; BLOOD; EARLY MENOPAUSE; FAMILY HEALTH; GENETIC SUSCEPTIBILITY; GENETICS; HORMONE SUBSTITUTION; INCIDENCE; MULTIMODALITY CANCER THERAPY; OVARIECTOMY; OVARY TUMOR; PEDIGREE; REMISSION; SMALL CELL CARCINOMA; TWINS;

ABDOMINAL PAIN; ADULT; AGE OF ONSET; ANTICIPATION, GENETIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CARCINOMA, SMALL CELL; CHEMOTHERAPY, ADJUVANT; CHILD; CISPLATIN; COMBINED MODALITY THERAPY; DISEASES IN TWINS; ETOPOSIDE; FAMILY HEALTH; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPERCALCEMIA; INCIDENCE; MENOPAUSE, PREMATURE; OVARIAN NEOPLASMS; OVARIECTOMY; PEDIGREE; RADIOTHERAPY, ADJUVANT; REMISSION INDUCTION;

EID: 70449709481     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22184     Document Type: Article

References (20)

1. Breen JL, Maxson WS. Ovarian tumors in children and adolescents. Clin Obstet Gynecol 1977;20:607-623.
2. Schultz KA, Sencer SF, Messinger Y, et al. Pediatric ovarian tumors: A review of 67 cases. Pediatr Blood Cancer 2005;44:167-173.
3. Amos CI, Struewing JP. Genetic epidemiology of epithelial ovarian cancer. Cancer 1993;71:566-572.
4. Piver MS, Baker TR, Jishi MF, et al. Familial ovarian cancer. A report of 658 families from the Gilda Radner Familial Ovarian Cancer Registry 1981-1991. Cancer 1993;71:582-588.
5. Walsh T, Casadei S, Coats KH, et al. Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. J Am Med Assoc 2006;295:1379-1388.
6. Dickersin GR, Kline IW, Scully RE. Small cell carcinoma of the ovary with hypercalcemia: A report of eleven cases. Cancer 1982;49:188-197.
7. Young RH, Oliva E, Scully RE. Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases. Am J Surg Pathol 1994;18:1102-1116.
8. Kanwar VS, Heath J, Krasner CN, et al. Advanced small cell carcinoma of the ovary in a seventeen-year-old female, successfully treated with surgery and multi-agent chemotherapy. Pediatr Blood Cancer 2008;50:1060-1062.
9. Benrubi GI, Pitel P, Lammert N. Small cell carcinoma of the ovary with hypercalcemia responsive to sequencing chemotherapy. South Med J 1993;86:247-248.
10. Caskey CT, Pizzuti A, Fu YH, et al. Triplet repeat mutations in human disease. Science 1992;256:784-789.
11. Orr HT, Chung MY, Banfi S, et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet 1993;4:221-226.
12. Trkova M, Prochazkova K, Krutilkova V, et al. Telomere length in peripheral blood cells of germline TP53 mutation carriers is shorter than that of normal individuals of corresponding age. Cancer 2007;110:694-702.
13. Tabori U, Nanda S, Druker H, et al.Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome. Cancer Res 2007;67:1415-1418.
14. Gruber SB, Mukherjee B. Anticipation in lynch syndrome: Still waiting for the answer. J Clin Oncol 2009;27:326-327.
15. Goldberg JM, Piver MS, Jishi MF, et al. Age at onset of ovarian cancer in women with a strong family history of ovarian cancer. Gynecol Oncol 1997;66:3-9.
16. Amos CI, Shaw GL, Tucker MA, et al. Age at onset for familial epithelial ovarian cancer. J Am Med Assoc 1992;268:1896-1899.
17. Lynch HT, Watson P, Bewtra C, et al. Hereditary ovarian cancer. Heterogeneity in age at diagnosis. Cancer 1991;67:1460-1466.
18. Ulbright TM, Roth LM, Stehman FB, et al. Poorly differentiated (small cell) carcinoma of the ovary in young women: Evidence supporting a germ cell origin. Hum Pathol 1987;18:175-184.
19. Lamovec J, Bracko M, Cerar O. Familial occurrence of small-cell carcinoma of the ovary. Arch Pathol Lab Med 1995;119:523-527.
20. Longy M, Toulouse C, Mage P, et al. Familial cluster of ovarian small cell carcinoma: A new Mendelian entity? J Med Genet 1996;33:333-335.